EMCORE Corporation to Host Fiscal 2024 Second Quarter Conference Call on May 8, 2024
May 02, 2024 16:03 ET
|
EMCORE Corporation
EMCORE Corporation to Host Fiscal 2024 Second Quarter Conference Call on May 8, 2024
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
May 02, 2024 16:02 ET
|
Ardelyx, Inc.
Company reports $45.6 million in Q1 product-related revenue, including $28.4 million in net product sales revenue for IBSRELA and $15.2 million in net product sales revenue for XPHOZAH Company ends...
BJ’s Restaurants, Inc. Reports Fiscal First Quarter 2024 Results
May 02, 2024 16:02 ET
|
BJ's Restaurants, Inc.
HUNTINGTON BEACH, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- BJ’s Restaurants, Inc. (NASDAQ: BJRI) today reported financial results for its fiscal 2024 first quarter ended Tuesday, April 2, 2024. ...
Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024
May 02, 2024 16:02 ET
|
Corvus Pharmaceuticals, Inc.
BURLINGAME, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference...
CSX Executive Vice President and Chief Commercial Officer to Address Bank of America Transportation, Airlines and Industrials Conference
May 02, 2024 16:02 ET
|
CSX Corporation
JACKSONVILLE, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) Executive Vice President and Chief Commercial Officer, Kevin Boone, will address the Bank of America Transportation,...
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
May 02, 2024 16:01 ET
|
Soleno Therapeutics
REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq:SLNO), ("Soleno" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics...
Mustang Bio Announces Closing of $4 Million Public Offering
May 02, 2024 16:01 ET
|
Mustang Bio, Inc.
WORCESTER, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical...
WW International, Inc. Announces First Quarter 2024 Results
May 02, 2024 16:01 ET
|
WW International Inc.
End of Period Subscribers of 4.0 million, including 91 thousand End of Period Clinical SubscribersRevenues of $206.5 millionGross margin of 66.7%; excluding the net impact of restructuring charges...
Galapagos reports first quarter 2024 financial results
May 02, 2024 16:01 ET
|
Galapagos NV
Advanced potentially best-in-class cell therapy and small molecule R&D pipeline comprising four clinical assets and >15 discovery programs in oncology and immunologyExecuted agreements with...
Ascendis Pharma Reports First Quarter 2024 Financial Results
May 02, 2024 16:01 ET
|
Ascendis Pharma
— Rollout of YORVIPATH® initiated in Germany and Austria, with an estimated 55 doctors writing prescriptions and ~100 patients receiving commercial product as of March 31 — TransCon™ PTH...